various. (2010). Drug policy guide. London: International Drug Policy Consortium (IDPC).
Abstract: This is the first edition of the IDPC Drug Policy Guide aimed at national government policy makers. This publication is a collaborative effort by a number of IDPC members and partners, and brings together global evidence and best practices on the design and implementation of drug policies and programmes at national level. We are in an era of uncertainty for national policy makers in this field – drug problems and related challenges are increasing and it is increasingly clear that simple ‘war on drugs’ approaches are not succeeding in eradicating the problem. There are a growing number of policy and programme options available to address the harms that are associated with drug markets and drug use. Politicians and officials therefore face the challenge of defining a set of policies and programmes that are appropriate for the situation in their country. This guide, and the network of expertise that exists across the IDPC, is designed to help in that process. Each chapter describes the nature of the policy challenges and the range of evidence and experiences around the world, and sets out advice and recommendations for effective policy going forward.
Keywords: government and politics; program planning; laws and regulations; AOD public policy strategy; AOD use, abuse, and dependence; drug market; recommendations or guidelines; cooperation; international area
|
Lapelosa, M., & Lapelosa, M. (1999). Rapporto sui programmi di distribuzione e cambio : distribuzione effettuata mediante macchine scambiasiringhe prodotte dalla ditta M.L. : dati rilevati periodo 1991 – 1999. Castelfranco: M.L. di Lapelosa Michele, Marco & C. S.n.c.
|
Simon, R., David-Spickermann, M., & Bartsch, G. (2006). 2006 national report to the EMCDDA by the REITOX National Focal Point : Germany : new developments, trends and in-depth information on selected topics : drug situation 2005. National report to the EMCDDA by the REITOX National Focal Point. Berlin: Deutsche Referenzstelle für die Europäische Beobachtungsstelle für Drogen und Drogensucht (DBDD).
Keywords: monitoring; legal issues; government and politics; public policy on AOD; strategy; AOD use, abuse, and dependence; epidemiology; adolescent; young adult; prevention; quality control; research; treatment and maintenance; AODR mortality; HIV infection; viral hepatitis; health and disease; stigma; prison; AODR crime; cost (economic); law enforcement; cocaine in any form; AOD use and driving; Germany
|
Degkwitz, P., & Zurhold, H. (2010). Die Bedarfe älterer Konsumierender illegaler Drogen : zukünftige Anforderungen an Versorgungskonzepte in der Sucht- und Altenhilfe in Hamburg. Hamburg: Hamburgische Landesstelle für Suchtfragen (HLS); Zentrum für Interdisziplinäre Suchtforschung der Universität Hamburg (ZIS).
Abstract: Eine empirische Untersuchung über die bestehenden und zu erwartenden gesundheitlichen und sozialen Problemen der zunehmend älter werdenden Drogenkonsumentinnen und Drogenkonsumenten in Hamburg
Keywords: AOD user; AOD dependent; old age; elderly; social work (field); Germany; Hamburg
|
Dobler-Mikola, A., Schaaf, S., & Uchtenhagen, A. (1994). Drogenabhängige in stationärer Behandlung : Durchführbarkeitsstudie zur Implementierung einer nationalen Klientendokumentation und Verlaufsevaluation. Zürich: Sozialpsychiatrischer Dienst der Psychiatrischen Universitätsklinik Zürich.
Keywords: treatment and maintenance; inpatient care; Switzerland
|
Buitelaar, J., Bergsma, A., & Sindelar, B. (2000). Attention deficit/hyperkinetic disorders : their diagnosis and treatment with stimulants. Strasbourg: Council of Europe Publishing.
Keywords: treatment and maintenance
|
Simoneau, H., Landry, M., Tremblay, J., Allemann, R., Conant, D., Gache, P., et al. (2009). Alcochoix+ : un guide pour choisir et atteindre vos objectifs : version adaptée pour la Suisse romande (Groupement romand d'études des addictions, Ed.). Yverdon-les-Bains: Groupement romand d'études des addictions (GREA).
Keywords: treatment and maintenance; outpatient care; addiction; AOD dependence; chemical addiction; alcohol; controlled drinking; Switzerland; French-speaking Switzerland
|
Observatoire européen des drogues et des toxicomanies. (2004). Rapport annuel 2004 : état du phénomène de la drogue dans l'Union Européenne et en Norvège. Luxembourg: Office des publications officielles des Communautés européennes.
Keywords: government and politics; international area; AOD public policy strategy; public policy on illicit drugs; other drug laws; target group; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; treatment and maintenance; prison; AODR crime; comorbidity; Europe; annual report
|
European Monitoring Centre for Drugs and Drug Addiction. (2004). Annual report 2004 : the state of the drugs problem in the European Union and Norway. Luxembourg: Office for Official Publications of the European Communities.
Keywords: government and politics; international area; AOD public policy strategy; public policy on illicit drugs; other drug laws; target group; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; treatment and maintenance; prison; AODR crime; comorbidity; Europe; annual report
|
Osservatorio europeo delle droghe e delle tossicodipendenze. (2004). Relazione annuale 2004 : evoluzione del fenomeno della droga nell'Unione europea ed in Norvegia. Relazione annuale. Lussemburgo: Ufficio delle pubblicazioni ufficiali delle Comunità europee.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; ketamine; gamma-hydroxybutyric acid; communicable disease; AODR mortality; Europe; annual report
|